Continuous Glucose Monitor

Veri CGM Program

Overview

Veri leverages proven Libre CGM technology backed by dozens of RCTs/meta-analyses for accuracy (MARD 9.3%) and efficacy in stabilizing glucose, with program data showing 72% user improvement (n=739). Safety is solid per FDA clearance but tempered by device recalls and MAUDE reports of inaccuracies. Quality benefits from established sensor but lacks supplement-style purity testing. Overall, effective for metabolic insights in healthy users vs category peers.

Key strengths

Our analysis

Veri CGM Program effectively delivers accurate glucose insights via FDA-cleared Libre sensors (9.3% MARD, strong RCT evidence) and app/coaching for metabolic health in non-diabetics. User data shows 72% improvement, but watch for sensor recalls. Good option at category-average pricing.

Frequently asked questions

Is Veri CGM Program worth buying?
Veri CGM Program has a Verify Influencers trust score of 72/100 based on ingredient quality, clinical evidence, and third-party testing.
What is the trust score for Veri CGM Program?
Veri CGM Program scored 72 out of 100 in our science-backed analysis, which evaluates ingredient dosages against clinical literature and manufacturing transparency.

Browse all scored products · How products are scored